cefalexin monohydrate 300 mg - otsingu tulemused

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cephex cefalexin (as monohydrate) 500mg capsule blister pack

amneal pharma australia pty ltd - cefalexin monohydrate -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cephex cefalexin (as monohydrate) 250mg capsule blister pack

amneal pharma australia pty ltd - cefalexin monohydrate -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cephatrust 500 cefalexin monohydrate 500 mg capsules blister pack

lupin australia pty limited - cefalexin -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cephatrust 250 cefalexin monohydrate 250 mg capsules blister pack

lupin australia pty limited - cefalexin -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cephalexin max cefalexin monohydrate 250 mg capsules blister pack

lupin australia pty limited - cefalexin, quantity: 250 mg - capsule - excipient ingredients: microcrystalline cellulose; patent blue v; sunset yellow fcf; gelatin; quinoline yellow; purified water; titanium dioxide; sodium lauryl sulfate; magnesium stearate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - respiratory tract infections caused by s. pneumoniae and group a beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin max capsule is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin capsule in the subsequent prevention of rheumatic fever are not available at present). bacterial sinusitis caused by streptococci, s. pneumoniae and s. aureus (methicillin sensitive only). otitis media. due to s. pneumoniae, staphylococci. skin and soft tissue infections. caused by staphylococci and/or streptococci. genitourinary tract infections, including acute prostatitis caused by e. coli, p. mirabilis and klebsiella sp. the effectiveness of cephalexin max capsule in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin max capsule is not indicated in these conditions. note: appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cephalexin max capsule. renal function studies should be performed when indicated.